INSIGHTS ON UPSTREAM MANUFACTURING

• WuXia293Stable: Express What CHO Can't

  Explore a modern 293‑based expression system built for higher purity, controlled glycosylation, and improved activity, offering a new option for teams developing complex or next‑generation biologics.

• A Highly Productive, Chemically Defined Exosome Media System

  Explore how chemically defined media and optimized bioreactor protocols increase exosome yields 40-fold while reducing commercial manufacturing costs from $10,000 to under $1,000 per dose.

• Where MSCs Go When Injected And Why It Matters

  Understand why IV-delivered MSCs undergo rapid apoptosis in lung tissue while locally implanted cells survive as programmable therapeutic factories—and how this knowledge enables rational MSC engineering.

• Engineering The Next Wave Of CHO Performance

  By combining improved productivity with speed and reliability, S-CHOice® 2G helps biopharmaceutical companies optimize their manufacturing strategies, reduce overall costs, and respond more effectively to market demands.

• Biocapacitance Measurement: A PAT Tool For Biomass Measurement In An Upstream Process

  3/20/2026

  Leverage process analytical technologies (PAT) to gain real-time insight into product quality, strengthen control strategies, and build more efficient, scalable manufacturing processes for future success.

• A Cell Line Development Platform Accelerating Timelines To Clinic

  3/20/2026

  To support a seamless transition from early clinical studies through to commercial manufacturing, cell line expression systems must be carefully designed and selected based on several critical attributes.

• LVV Manufacturing: Old But Gold Gene Therapy Viruses?

  3/20/2026

  Discover how plasmid design, transfection protocols, and controlled freezing methods combine to address critical manufacturing challenges in lentiviral vector production for gene therapy applications.

• Accelerating Vector Construction-To-IND: Achieving A 9-Month Timeline Through Integrated Cell Line Development

  3/19/2026

  Uncover how tighter alignment between vector construction and cell banking improved development efficiency, strengthened risk management, and enhanced early-stage program outcomes.